To the full analysis
Roivant Sciences stock: growth
ROIVRoivant Sciences reported $8.26M in revenue for fiscal 2025, down 71.6% on the prior year, down 7.6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−29.6%
per year from 2019 to 2025, per share −29.7%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2019 | |
|---|---|---|
| Revenue | −19.1% | −29.6% |
| Revenue per share | −19.3% | −29.7% |
| Earnings | no data | no data |
| Earnings per share | no data | no data |
| Free cash flow | no data | no data |
| Free cash flow per share | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2019 | $67.69M | $1.2B | −$766.75M |
| 2020 | $23.8M | −$809.23M | −$557.94M |
| 2021 | $55.29M | −$845.26M | −$695.17M |
| 2022 | $31.53M | −$1.01B | −$856.08M |
| 2023 | $32.71M | $4.35B | −$766.65M |
| 2024 | $29.05M | −$171.98M | −$844.05M |
| 2025 | $8.26M | −$299.77M | −$758.56M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Mar 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 22 May 2026)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.